Determining a clinical framework for use of cefepime and -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae
出版年份 2013 全文链接
标题
Determining a clinical framework for use of cefepime and -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 69, Issue 4, Pages 871-880
出版商
Oxford University Press (OUP)
发表日期
2013-11-22
DOI
10.1093/jac/dkt450
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam
- (2013) Michael N. Dudley et al. CLINICAL INFECTIOUS DISEASES
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
- (2012) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
- (2012) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Editorial Commentary: Saving Lives With Optimal Antimicrobial Chemotherapy
- (2012) G. L. Drusano et al. CLINICAL INFECTIOUS DISEASES
- Transmission Dynamics of Extended-Spectrum β-lactamase–Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting
- (2012) Markus Hilty et al. CLINICAL INFECTIOUS DISEASES
- Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters
- (2012) Nan-Yao Lee et al. CLINICAL INFECTIOUS DISEASES
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
- (2012) K. Z. Vardakas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
- (2012) Wouter C. Rottier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?
- (2012) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Piperacillin–tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
- (2012) Cheol-In Kang et al. JOURNAL OF INFECTION
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
- (2011) J.W. Mouton et al. CLINICAL MICROBIOLOGY AND INFECTION
- Revisiting Beta-lactams – PK/PD improves dosing of old antibiotics
- (2011) Alasdair MacGowan CURRENT OPINION IN PHARMACOLOGY
- Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective
- (2011) Johan W. Mouton et al. DRUG RESISTANCE UPDATES
- Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli
- (2011) M. Hombach et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2010) D. J. Hoban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008
- (2010) S. Hawser et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues
- (2010) K. S. Thomson JOURNAL OF CLINICAL MICROBIOLOGY
- Pharmacokinetics, Pharmacodynamics, and Monte Carlo Simulation
- (2010) John S. Bradley et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis
- (2009) Jesús Rodríguez‐Baño et al. CLINICAL INFECTIOUS DISEASES
- Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
- (2009) Leonardo Lorente et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The changing epidemiology of resistance
- (2009) P. M. Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cephalosporin MIC Distribution of Extended-Spectrum- -Lactamase- and pAmpC-Producing Escherichia coli and Klebsiella Species
- (2009) P. C. Kohner et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Extended-spectrum β-Lactamases: Implications for the Clinical Laboratory and Therapy
- (2009) Sohei Harada et al. Korean Journal of Laboratory Medicine
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations
- (2008) A. MacGowan CLINICAL MICROBIOLOGY AND INFECTION
- Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
- (2008) G. Kahlmeter CLINICAL MICROBIOLOGY AND INFECTION
- Cefepime: a reappraisal in an era of increasing antimicrobial resistance
- (2008) Andrea Endimiani et al. Expert Review of Anti-Infective Therapy
- Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation
- (2008) Christopher R. Frei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid Emergence of blaCTX-M Among Enterobacteriaceae in U.S. Medical Centers: Molecular Evaluation from the MYSTIC Program (2007)
- (2008) Mariana Castanheira et al. Microbial Drug Resistance
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started